Otros idiomas Telesis Bio, Inc.

Acciones

TBIO

US1920032000

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
3,65 ^USD	-8,29 %		+5,80 %	-49,18 %

09/05	Telesis Bio, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
18/04	Telesis Bio, Inc. anuncia el nombramiento de Eric Esser como miembro del consejo de administración	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Telesis Bio: Q1 Earnings Snapshot	09/05
Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	09/05
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Telesis Bio Reports First Quarter 2024 Financial Results	09/05
Telesis Bio Announces Reverse Stock Split	06/05
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership	18/04
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	18/04
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	18/04
Telesis Bio, Inc. Announces Chief Executive Officer Changes	18/04
Telesis Bio : Shareholder Meeting - Form 8-K	08/04
Telesis Bio: Q4 Earnings Snapshot	28/03
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M	28/03
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results	28/03
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	28/03
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	27/02
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26/02
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26/02
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?	23/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Telesis Bio, Inc.

Acciones

TBIO

US1920032000

Otros idiomas

Filtros